Li Ning, Hansen Brian J, Csepe Thomas A, Zhao Jichao, Ignozzi Anthony J, Sul Lidiya V, Zakharkin Stanislav O, Kalyanasundaram Anuradha, Davis Jonathan P, Biesiadecki Brandon J, Kilic Ahmet, Janssen Paul M L, Mohler Peter J, Weiss Raul, Hummel John D, Fedorov Vadim V
Department of Physiology and Cell Biology, Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Dorothy M. Davis Heart and Lung Research Institute, Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Sci Transl Med. 2017 Jul 26;9(400). doi: 10.1126/scitranslmed.aam5607.
The human sinoatrial node (SAN) efficiently maintains heart rhythm even under adverse conditions. However, the specific mechanisms involved in the human SAN's ability to prevent rhythm failure, also referred to as its robustness, are unknown. Challenges exist because the three-dimensional (3D) intramural structure of the human SAN differs from well-studied animal models, and clinical electrode recordings are limited to only surface atrial activation. Hence, to innovate the translational study of human SAN structural and functional robustness, we integrated intramural optical mapping, 3D histology reconstruction, and molecular mapping of the ex vivo human heart. When challenged with adenosine or atrial pacing, redundant intranodal pacemakers within the human SAN maintained automaticity and delivered electrical impulses to the atria through sinoatrial conduction pathways (SACPs), thereby ensuring a fail-safe mechanism for robust maintenance of sinus rhythm. During adenosine perturbation, the primary central SAN pacemaker was suppressed, whereas previously inactive superior or inferior intranodal pacemakers took over automaticity maintenance. Sinus rhythm was also rescued by activation of another SACP when the preferential SACP was suppressed, suggesting two independent fail-safe mechanisms for automaticity and conduction. The fail-safe mechanism in response to adenosine challenge is orchestrated by heterogeneous differences in adenosine A1 receptors and downstream GIRK4 channel protein expressions across the SAN complex. Only failure of all pacemakers and/or SACPs resulted in SAN arrest or conduction block. Our results unmasked reserve mechanisms that protect the human SAN pacemaker and conduction complex from rhythm failure, which may contribute to treatment of SAN arrhythmias.
人类窦房结(SAN)即使在不利条件下也能有效地维持心律。然而,人类窦房结预防节律衰竭(也称为其稳健性)能力所涉及的具体机制尚不清楚。存在挑战的原因是人类窦房结的三维(3D)壁内结构与经过充分研究的动物模型不同,并且临床电极记录仅限于心房表面激活。因此,为了创新人类窦房结结构和功能稳健性的转化研究,我们整合了壁内光学标测、3D组织学重建以及离体人类心脏的分子标测。当受到腺苷或心房起搏挑战时,人类窦房结内多余的结内起搏器维持自律性,并通过窦房传导通路(SACPs)将电冲动传递至心房,从而确保了一种用于稳健维持窦性心律的故障安全机制。在腺苷干扰期间,主要的中央窦房结起搏器受到抑制,而先前不活跃的 superior 或 inferior 结内起搏器接管了自律性维持。当优先的 SACP 受到抑制时,另一条 SACP 的激活也挽救了窦性心律,这表明存在两种独立的用于自律性和传导的故障安全机制。对腺苷挑战的故障安全机制是由整个窦房结复合体中腺苷 A1 受体和下游 GIRK4 通道蛋白表达的异质性差异所协调的。只有所有起搏器和/或 SACPs 均失效才会导致窦房结停搏或传导阻滞。我们的研究结果揭示了保护人类窦房结起搏器和传导复合体免于节律衰竭的储备机制,这可能有助于治疗窦房结心律失常。